Novavax + Emergent: In the news

03.23.2020

Original news coverage of Novavax's agreement with Emergent BioSolutions to manufacture and develop an experimental oral vaccine candidate for the Coronavirus Disease.

Nasdaq: #TradeTalks: Accelerating the Development of a Treatment for COVID-19 (March 14, 2020)
Fox Baltimore: Maryland company working on COVID-19 vaccine (March 12, 2020)

CNBC: Emergent BioSolutions partners with Novavax to develop coronavirus vaccine (March 12, 2020)

Pick up: Benzinga, MSN

Yahoo Finance: Emergent BioSolutions collaborates for coronavirus vaccine (March 12, 2020)
Fox Business: Coronavirus vaccine to go into clinical stage soon: Emergent Biosolutions president (March 12, 2020)

MSN: Coronavirus vaccine to go into clinical stage soon: Emergent Biosolutions president (March 12, 2020)

Wall Street Journal: As Virus Spreads, Drugmakers Are On the Case (March 12, 2020)
Wall Street Journal: Emergent BioSolutions Is Developing Potential Coronavirus Treatments (March 11, 2020)

Emergent CDMO

Novovax COVID-19 In The News

03.19.2020

Novavax agreement for Experimental Vaccine Candidate for Coronavirus Disease

GAITHERSBURG, Md.,March 10, 2020(GLOBE NEWSWIRE) --Emergent BioSolutions Inc.(NYSE:EBS) announced today that it has entered...

04.01.2020

Emergent BioSolutions Signs Agreement with Novavax to Manufacture NanoFlu™

CDMO agreement for NanoFlu to support pathway to licensure
Expanded collaboration now includes NanoFlu and COVID-19 vaccine...

03.23.2020

Vaxart + Emergent: In the news

Original news coverage of Vaxart's agreement with Emergent BioSolutions to manufacture and develop an experimental oral vaccine...